Navigation Links
Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
Date:1/7/2008

FRAZER, Pa., Jan. 7 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that the presentation slides that will be used by the company at the JPMorgan Healthcare Conference are now available on the "Investor Information" section of the company's website at http://www.cephalon.com. On Tuesday, January 8, 2008, Frank Baldino, Jr., Ph.D., Chairman and CEO, will deliver a one hour presentation at the Conference beginning at 2:00 p.m. Pacific Time (5 p.m. Eastern Time).

Live Web Cast and Archived Replay

Members of the financial and investment community, the media and other interested parties can access a live web cast of the presentation through the Investor Information section of the company's website http://www.cephalon.com. Following the live presentation, a replay of the presentation will be available for two weeks on the Company's website.

About Cephalon, Inc.

Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. A member of the Fortune 1000, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota. Cephalon's European headquarters are located in Maisons-Alfort, France.

The company's proprietary products in the United States include: PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA(R) (fentanyl buccal tablet) [C-II], TRISENOX, AMRIX(R) (cyclobenzaprine hydrochloride extended-release capsules), VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydroch
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
2. Cephalon Submits Supplemental New Drug Application for FENTORA
3. Cephalon Announces Strong Third Quarter Financial Results
4. Cephalon Quarterly Conference Call Invitation
5. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
6. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
7. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
11. Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., Md., Nov. 30 Novavax, ...pany, announced today that the company will be pre...2009 on December 2, 2009 at 12:30 pm local time at...ide an overview of the company,s business strategy...ilestones. A link to the live audio only presenta...
(Date:11/30/2009)...v. 30 Dr. Jessica Torrente, Assist...iversity Medical Center in Washington, D.C., demon... Gamma Imaging (BSGI) in clinical practice as an a...t cancer today at the annual meeting of the Radiol... purpose of the exhibit was to demonstrate how BSG...
(Date:11/30/2009)...if., Nov. 30 BioMarin Ph... that the Food and Drug Administration (FDA) has g...dine (3,4-DAP), amifampridine phosphate, for the r...ndrome (LEMS). 3,4-DAP has previously received or...r 2009, the Committee for Medicinal Products for H...
(Date:11/30/2009)...nd COPENHAGEN, Nov. 30 Exiqon A/S ...t the Harvard Medical School ICCB-Longwood Screeni...oRNA Screening Center of Excellence. ICCB-L suppo...ssociated hospitals and institutions, for high-thr...ries. ,, MicroRNAs are a novel class of small, ...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3
...- $15 million development milestone payment to Int...ram in Phase 2 -, BRISBANE, Calif., Sept. 2 Inte...InterMune has earned a $15 million,development mil...che for,the hepatitis C virus (HCV) NS3 protease i...t Roche), currently in a Phase 1b clinical trial i...
...SAN MATEO, Calif., Sept. 2 NeurogesX, Inc.,(Nasda... developing and,commercializing novel pain managem...o, President and Chief Executive Officer, is sched...hcare Unplugged Conference in New,York City on Tue...higlieri,Chief Financial Officer, will be availabl...
...BETHESDA, Md., Sept. 2 Micromet, Inc.,(Nasdaq: M...utical company,developing novel, proprietary antib... autoimmune diseases, today announced the appointm...t and Chief Financial Officer.,Mr. Phillips has se...rs,since 2000, and was the chair of the nominating...
Other Biology Technology:InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 2InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 3InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 4NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference 2NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference 3Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer 2Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer 3Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer 4
(Date:11/26/2009)... at last worked out a way of using recordings of b...ulations. This is the first time sound recordings ...accurate estimates of bird species, populations. B...Ecological Society,s Journal of Applied Ecology ,...a major advance in our ability to monitor whale an...
(Date:11/25/2009)....Scientists at the California Institute of Technol...ve emotion-like behavior in the fruit fly, Drosop...be relevant to the relationship between the neurot...ivity disorder (ADHD), are described in the Decemb...ila brain contains only about 20,000 neurons and ...
(Date:11/25/2009)...VEMBER 25, 2009 Soil is the linchpin of the envir...re meet. Despite that, many students see soil as "...re. Soil science educators are challenged with the... the critical importance of soil in the environmen...d earth science teachers at University of Nebraska...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4It's not just dirt! 2UN Gathering of Global Experts to Address Current Crisis in Family Planning 50103 1UN Gathering of Global Experts to Address Current Crisis in Family Planning 50103 2Too Few Americans Get HIV Test Early Enough 50100 1Too Few Americans Get HIV Test Early Enough 50100 2Too Few Americans Get HIV Test Early Enough 50100 3The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 1The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 2The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 3The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 4
...shed the findings of a team of scientists at the n...t provides a whole genome analysis of the protein ...ism known as Dictyostelium. , Led by Dr. Janet S...e evolution of kinases, which are enzymes involved...5% of human genes code for protein kinases, and mu...
...earchers and their colleagues have discovered a ne...a cancer-causing virus found in mice. Their findin...fection with a retrovirus that is native to rodent...nts with a rare type of prostate cancer. The patie...romised some of their natural defenses against vir...
...nnesota were successful in using robotic surgery t...sue in pigs. , Using minimally invasive robotic s...lls into the damaged hearts. The cells were "label...be able to see if they engrafted in the pig hearts...six of seven cases. Subsequent MRI studies showed...
Other Biology News:Scientists elucidate the kinome of key model organism 2New human retrovirus originated in mice 2New human retrovirus originated in mice 3New human retrovirus originated in mice 4U of MN uses robotic surgery techniques in cardiac cell therapy research 2
BD FACSArray bioanalyzer from BD Biosciences - Immunocytometry Systems
...capability allows detection of SYBR Green I or FAM... in the second channel including TET, HEX, VIC, a...RT-qPCR and allelic discrimination. DNA Engine the... temperature gradient feature permits simultaneous...
SlideHyb Glass Array Hybridization Buffer #2 from Ambion
Fingerprinting II Informatix Dimensioning Techniques from Bio-Rad
Biology Products: